Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of corticosteroids in cystic fibrosis lung disease.

× No keyword cloud information.

33 in total

Review 1. Pathogenesis and management of aspergillosis in cystic fibrosis.

Authors: E J Hiller
Journal: Arch Dis Child Date: 1990-04 Impact factor: 3.791

Review 2. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma.

Authors: R P Schleimer
Journal: Am Rev Respir Dis Date: 1990-02

Review 3. Glucocorticoid receptors and actions.

Authors: A Munck; D B Mendel; L I Smith; E Orti
Journal: Am Rev Respir Dis Date: 1990-02

Review 4. Inhaled corticosteroid therapy in children: an assessment of the potential for side effects.

Authors: G Russell
Journal: Thorax Date: 1994-12 Impact factor: 9.139

5. Nyctohemeral rhythm of plasma renin activity and plasma aldosterone in children.

Authors: M Dechaux; M Broyer; G Lenoir; J M Limal; C Sachs
Journal: Pediatr Res Date: 1982-05 Impact factor: 3.756

6. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.

Authors: H S Auerbach; M Williams; J A Kirkpatrick; H R Colten
Journal: Lancet Date: 1985-09-28 Impact factor: 79.321

7. Progression of cystic fibrosis lung disease as a function of serum immunoglobulin G levels: a 5-year longitudinal study.

Authors: W B Wheeler; M Williams; W J Matthews; H R Colten
Journal: J Pediatr Date: 1984-05 Impact factor: 4.406

8. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.

Authors: R B Fick; R A Robbins; S U Squier; W E Schoderbek; W D Russ
Journal: Pediatr Res Date: 1986-12 Impact factor: 3.756

9. Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.

Authors: C F Pantin; R J Stead; M E Hodson; J C Batten
Journal: Thorax Date: 1986-01 Impact factor: 9.139

10. Risk factors for the development of posterior subcapsular cataracts in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis treated with corticosteroids.

Authors: M Majure; S Mroueh; A Spock
Journal: Pediatr Pulmonol Date: 1989

5 in total

1. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis.

Authors: I M Balfour-Lynn; N J Klein; R Dinwiddie
Journal: Arch Dis Child Date: 1997-08 Impact factor: 3.791

2. Reduced upper airway nitric oxide in cystic fibrosis.

Authors: I M Balfour-Lynn; A Laverty; R Dinwiddie
Journal: Arch Dis Child Date: 1996-10 Impact factor: 3.791

Review 3. Mucosal Immunity in Cystic Fibrosis.

Authors: Christine M Bojanowski; Shiping Lu; Jay K Kolls
Journal: J Immunol Date: 2021-12-15 Impact factor: 5.426

Review 4. Oral steroids for long-term use in cystic fibrosis.

Authors: Katharine Cheng; Deborah Ashby; Rosalind L Smyth
Journal: Cochrane Database Syst Rev Date: 2015-12-09

5. Evidence for a Cystic Fibrosis Enteropathy.

Authors: Marlou P M Adriaanse; Linda J T M van der Sande; Anita M van den Neucker; Paul P C A Menheere; Edward Dompeling; Wim A Buurman; Anita C E Vreugdenhil
Journal: PLoS One Date: 2015-10-20 Impact factor: 3.240

5 in total